![Alfredo Zurlo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfredo Zurlo
Plus aucun poste en cours
Profil
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A. Zurlo holds a doctorate degree from The American University of Rome.
Anciens postes connus de Alfredo Zurlo
| Sociétés | Poste | Fin |
|---|---|---|
| MOLOGEN AG | Directeur Technique/Scientifique/R&D | 31/03/2016 |
| SCANDION ONCOLOGY A/S | Directeur Technique/Scientifique/R&D | - |
Glycotope GmbH
 Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Directeur Général | - |
Formation de Alfredo Zurlo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The American University of Rome
 The American University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Glycotope GmbH
Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Technology Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
